tiprankstipranks
Trending News
More News >
US Stem Cell Inc (DE:BHV)
BERLIN:BHV
Germany Market

US Stem Cell (BHV) Income Statement

Compare
0 Followers

US Stem Cell Income Statement

Last quarter (Q3 2023), US Stem Cell's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, US Stem Cell's net income was $0.00. See US Stem Cell’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 82.05K$ 200.75K$ 277.09K$ 3.07M$ 6.70M
Gross Profit
$ 58.28K$ 148.72K$ 212.97K$ 1.74M$ 4.59M
Operating Expenses
$ 1.78M$ 2.28M$ 2.61M$ 5.15M$ 5.69M
Depreciation and Amortization
$ -447.48K$ -151.41K$ -23.36K$ 461.41K$ 207.13K
EBITDA
$ -2.17M$ -2.29M$ -2.40M$ -2.51M$ -508.49K
Operating Income
$ -1.72M$ -2.14M$ -2.40M$ -3.42M$ -1.10M
Other Income/Expenses
$ -1.14M$ -1.15M$ -490.25K$ -418.48K$ -1.06M
Pretax Income
$ -2.86M$ -3.29M$ -2.89M$ -3.84M$ -2.16M
Net Income
$ -2.86M$ -4.29M$ -3.38M$ -5.04M$ -2.16M
Per Share Metrics
Basic EPS
$ 0.00$ -0.01$ -0.01$ -0.01$ -0.01
Diluted EPS
$ 0.00$ -0.01$ -0.01$ -0.01$ -0.01
Weighted Average Shares Outstanding
591.56M 460.79M 429.29M 398.04M 365.64M
Weighted Average Shares Outstanding (Diluted)
591.56M 460.79M 429.29M 398.04M 365.64M
Currency in USD

US Stem Cell Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis